Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED‐HF
Authors:
Open Access
- 22 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 23 (2) , 293-301
Abstract
Aims: To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM). Methods and results: TRED‐HF was a randomized controlled trial with a follow‐on single‐arm cross‐over phase that examined the safety and feasibility of therapy withdrawal in patients with recovered DCM over 6 months. The primary endpoint was relapse of heart failure defined by (i) a reduction in left ventricular (LV) ejection fraction >10% and to 10% increase in LV end‐diastolic volume and to above the normal range, (iii) a twofold rise in N‐terminal pro‐B‐type natriuretic peptide and to >400 ng/L, or (iv) evidence of heart failure. LV mass, LV and right ventricular (RV) global longitudinal strain (GLS) and extracellular volume were measured using cardiovascular magnetic resonance at baseline and follow‐up (6 months or relapse) for 48 patients. LV cell and extracellular matrix masses were derived. The effect of withdrawing therapy, stratified by relapse and genotype, was investigated in the randomized and follow‐on phases. In the randomized comparison, withdrawing therapy led to an increase in mean LV mass [5.4 g/m 2 ; 95% confidence interval (CI) 1.3–9.5] and cell mass (4.2 g/m 2 ; 95% CI 0.5–8.0) and a reduction in LV (3.5; 95% CI 1.6–5.5) and RV (2.4; 95% CI 0.1–4.7) GLS . In a non‐randomized comparison of all patients ( n = 47) who had therapy withdrawn in either phase , there was an increase in LV mass (6.2 g/m 2 ; 95% CI 3.6–8.9; P = 0.0001), cell mass (4.0 g/m 2 ; 95% CI 1.8–6.2; P = 0.0007) and matrix mass (1.7 g/m 2 ; 95% CI 0.7–2.6; P = 0.001) and a reduction in LV GLS (2.7; 95% CI 1.5–4.0; P = 0.0001). Amongst those who had therapy withdrawn and did not relapse , similar changes were observed ( n = 28; LV mass: 5.1 g/m 2 , 95% CI 1.5–8.8, P = 0.007; cell mass: 3.7 g/m 2 , 95% CI 0.3–7.0, P = 0.03; matrix mass: 1.7 g/m 2 , 95% CI 0.4–3.0, P = 0.02; LV GLS: 1.7, 95% CI 0.1–3.2, P = 0.04). Patients with TTN variants ( n = 10) who had therapy withdrawn had a greater increase in LV matrix mass (mean effect of TTN : 2.6 g/m 2 ; 95% CI 0.4–4.8; P = 0.02). Conclusion: In TRED‐HF, withdrawing therapy caused rapid remodelling, with early tissue and functional changes, even amongst patients who did not relapse.Keywords
Funding Information
- Rosetrees Trust
This publication has 18 references indexed in Scilit:
- Predictors of Left Ventricular Remodelling in Patients with Dilated Cardiomyopathy – A Cardiovascular Magnetic Resonance StudyEuropean Journal of Heart Failure, 2020
- The Myocardial Interstitium: The Principal Therapeutic Target of the 21st Century?JACC: Cardiovascular Imaging, 2019
- The Interstitium in the Hypertrophied HeartJACC: Cardiovascular Imaging, 2019
- Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialThe Lancet, 2019
- Sex- and Age-Based Differences in the Natural History and Outcome of Dilated CardiomyopathyEuropean Journal of Heart Failure, 2018
- Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmiasEuropean Heart Journal, 2018
- Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical TreatmentJACC, 2011
- Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial FibrosisCirculation, 2010
- Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic ResonanceJournal of Cardiovascular Magnetic Resonance, 2006
- The cellular basis of dilated cardiomyopathy in humansJournal of Molecular and Cellular Cardiology, 1995